Intermountain Primary Children's Hospital is a nationally ranked pediatric acute care children's teaching hospital located in Salt Lake City, Utah. The hospital has 289 pediatric beds and is affiliated with the University of Utah School of Medicine.

There are 289 beds in University of Utah / Primary Children's Hospital.

During the past decade, University of Utah / Primary Children's Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Utah / Primary Children's Hospital" #1 sponsor was "SK Life Science, Inc." with 2 trials, followed by "Takeda" with 2 trials sponsored, "Astellas Pharma Global Development, Inc." with 1 trials sponsored, "Bio Products Laboratory" with 1 trials sponsored and "BioFire Diagnostics, LLC" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Utah / Primary Children's Hospital" #1 collaborator was "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Alberta Children's Hospital" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Child and Family Research Institute" with 1 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "University of Utah / Primary Children's Hospital" are "Lennox Gastaut Syndrome" (2 trials), "Lennox Gastaut Syndrome (LGS)" (2 trials), "Churg Strauss Syndrome (Eosinophilic Granulomatosis With Polyangiitis)" (1 trials), "Common Variable Immunodeficiency" (1 trials) and "Congenital Heart Disease" (1 trials). Many other conditions were trialed in "University of Utah / Primary Children's Hospital" in a lesser frequency.

Most popular intervention types in "University of Utah / Primary Children's Hospital" are "Drug" (5 trials), "Other" (2 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carisbamate" (2 trials), "Soticlestat" (2 trials), "35-week delivery" (1 trials), "38-week delivery" (1 trials) and "FilmArray™ Gastrointestinal (GI) Panel" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Utah / Primary Children's Hospital" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Utah / Primary Children's Hospital". 1 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of Utah / Primary Children's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Utah / Primary Children's Hospital, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".